⏳ Fetching live dividend data...
Home › Calculator › OPK Dividend Calculator 2026
OPKO Health, Inc. · NASDAQ
Price: $1.46 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in OPK → $15765639681507.57M in 10 years · $1,312,867,375,948,115,200.00/month
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OPK position with:
Real after-tax yield depends on where you live and how you hold OPK.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 136.99% | 134.19% | $13,699 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 116.44% | 113.64% | $11,644 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 109.59% | 106.79% | $10,959 / yr |
| 🇬🇧 UK ISA | 0% | 136.99% | 134.19% | $13,699 / yr |
| 🇬🇧 UK Taxable | 8.75% | 125.00% | 122.20% | $12,500 / yr |
| 🇨🇦 TFSA | 0% | 136.99% | 134.19% | $13,699 / yr |
| 🇨🇦 CA Taxable | 25% | 102.74% | 99.94% | $10,274 / yr |
| 🇦🇺 Super (pension) | 15% | 116.44% | 113.64% | $11,644 / yr |
| 🇦🇺 AU Taxable | 30% | 95.89% | 93.09% | $9,589 / yr |
| 🇩🇪 DE Taxable | 26.375% | 100.86% | 98.06% | $10,086 / yr |
| 🇫🇷 FR Taxable | 30% | 95.89% | 93.09% | $9,589 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
OPK pays quarterly — 4 times per year. Next ex-div: TBD.
How OPK compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OPK sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-03-20 | 10,000 | $1.14 | $11.3K | ||
| A-Award | 2026-03-18 | 50,000 | $1.17 | $58.5K | ||
| Buy | 2025-11-21 | 192,870 | $1.33 | $257.5K | ||
| Buy | 2025-11-21 | 191,490 | $1.33 | $254.7K | ||
| Buy | 2025-11-21 | 89,375 | $1.32 | $118.4K | ||
| Buy | 2025-11-21 | 3,894 | $1.32 | $5.1K | ||
| Buy | 2025-11-21 | 102,371 | $1.30 | $133.1K | ||
| Buy | 2025-11-20 | 13,664 | $1.35 | $18.4K | ||
| Buy | 2025-11-20 | 1,757 | $1.34 | $2.4K | ||
| Buy | 2025-11-20 | 24,579 | $1.34 | $32.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OPK dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →